Only ~5% of breast cancer cases had FAT1 mutations, with gene amplifications and deep deletions being rare while missense mutations (either shallow or diploid) were more common including a small number of truncating mutations (Fig. S1F). Here, FAT1 is linked to breast carcinoma.